2m 2m 2m 2m 2m 2m 2m
KIORA PHARMA (KPRX)
NASDAQ
$2.60$0.00 (0.00%)
Price as of Jun 23, 2026 4:10 PM EDT- $10.9MMarket Cap
- -21.09%1-Year Change
- BiotechnologyIndustry
KIORA PHARMA (KPRX)
$2.60$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 16.0M N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 -100.00% | 16.0M N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -10.8M +37.47% | -7.8M +94.74% | -4.0M +16.76% | -3.4M -35.54% | |
Depreciation and Amortization Expense | 24,801 +29.14% | 19,205 -62.92% | 51,798 +24.49% | 41,609 -8.14% | |
Total Operating Expenses | 12.8M +11.48% | 11.5M -8.56% | 12.6M +2.25% | 12.3M -13.53% | |
Operating Profit | -12.8M -384.48% | 4.5M +135.83% | -12.6M +2.25% | -12.3M -13.53% | |
Interest Income | 894,002 -28.64% | 1.3M +620.07% | 173,989 +205.83% | 56,891 +4,886.06% | |
Interest Expense | N/A N/A | N/A N/A | -11,132 +29.46% | -8,599 +25.51% | |
Interest Income and Expense and Net | 894,002 -28.64% | 1.3M +669.29% | 162,857 +237.23% | 48,292 +945.74% | |
Total Nonoperating Income and Expense | 713,770 -37.90% | 1.1M +603.81% | 163,319 +111.77% | -1.4M -609.06% | |
Income before Taxes | -12.1M -314.10% | 5.7M +145.56% | -12.4M -9.29% | -13.7M -1.91% | |
Income Taxes | -1.3M -162.09% | 2.1M +2,186.35% | 90,319 +179.92% | -113,010 -41.32% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -10.8M -401.42% | 3.6M +128.73% | -12.5M -7.88% | -13.6M -1.36% | |
Net Income from Continuing Operations Applicable to Common | -12.1M -314.10% | 5.7M +145.56% | -12.4M -9.29% | -13.7M -1.91% | |
Basic EPS and Net Income | -2.60 -379.57% | 0.93 +134.57% | -2.69 -85.50% | -18.55 +1,197.20% | |
Diluted EPS and Net Income | -2.64 -403.45% | 0.87 +132.34% | -2.69 -85.50% | -18.55 +1,197.20% | |
Basic Weighted Average Shares | 4.2M +7.59% | 3.9M -20.02% | 4.8M +561.21% | 732,303 -92.41% | |
Diluted Weighted Average Shares | 4.1M -0.51% | 4.1M -14.81% | 4.8M +561.21% | 732,303 -92.41% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 8.7M +129.32% | 3.8M +54.49% | 2.5M -58.85% | 6.0M -24.50% | |
Short-Term Investments | 8.4M -63.51% | 23.0M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 17.1M -36.22% | 26.8M +991.47% | 2.5M -58.85% | 6.0M -24.50% | |
Total Current Assets | 21.7M -26.79% | 29.7M +526.97% | 4.7M -38.31% | 7.7M -14.57% | |
Accumulated Depreciation | 25,912 +2,430.47% | 1,024 -83.72% | 6,289 -94.64% | 117,319 +3.70% | |
Property and Plant and Equipment and Net | 91,672 +1,652.14% | 5,232 -35.13% | 8,065 -85.38% | 55,177 -25.44% | |
Total Long-Term Assets | 59,687 +139.58% | 24,913 -38.89% | 40,767 +23.54% | 33,000 -23.19% | |
Total Assets | 24.3M -33.52% | 36.5M +166.08% | 13.7M -26.59% | 18.7M -7.21% | |
Income Taxes Payable | 102,152 -79.18% | 490,690 -37.05% | 779,440 +13.11% | 689,121 -14.09% | |
Total Short-Term Debt | 0 N/A | N/A N/A | N/A N/A | 100,000 -52.89% | |
Total Current Liabilities | 3.6M -39.56% | 6.0M +267.73% | 1.6M -50.07% | 3.3M +103.30% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 4.5M -4.68% | 4.7M -20.98% | 6.0M +49.27% | 4.0M +1.44% | |
Total Liabilities | 8.1M -24.22% | 10.7M +41.07% | 7.6M +4.56% | 7.3M +30.97% | |
Retained Earnings | -154.2M +7.56% | -143.4M -2.45% | -147.0M +9.31% | -134.5M +11.24% | |
Total Stockholders Equity | 16.1M -37.40% | 25.8M +321.62% | 6.1M -46.44% | 11.4M -21.75% | |
Total Shares Outstanding | 3.8M +25.36% | 3.0M -61.06% | 7.7M +328.93% | 1.8M -85.81% | |
Cash Flow | |||||
Cash from Operating Activities | -10.0M -216.38% | 8.6M +189.56% | -9.6M -8.35% | -10.4M -2.32% | |
Capital Expenditures | 110,789 +1,670.92% | 6,256 N/A | N/A N/A | 0 -100.00% | |
Cash from Investing Activities | 14.4M +163.66% | -22.7M N/A | 0 -100.00% | 6,375 +104.06% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 265,655 -98.29% | 15.5M +159.77% | 6.0M -30.80% | 8.6M -50.97% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | 28.15% N/A | N/A N/A | N/A N/A | |
Return on Assets | -35.68% -349.10% | 14.32% +118.54% | -77.27% +10.38% | -70.00% -10.31% | |
Return on Equity | -51.74% -329.34% | 22.56% +115.79% | -142.88% +36.67% | -104.54% -18.09% | |
Revenue Growth | -100.00% N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 5.99 +21.14% | 4.94 +70.49% | 2.90 +23.54% | 2.35 -57.98% | |
Cash Ratio | 2.39 +279.46% | 0.63 -57.99% | 1.50 -17.58% | 1.82 -62.86% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow